Rémi Forrat

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

Sri Rezeki Hadinegoro, José Luis Arredondo-Garcı́a, Maria Rosario Capeding et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All

Farshad Guirakhoo, Scott Kitchener, Dennis Morrison et al. · Human Vaccines · 2006 · 192 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes in<i>Flavivirus</i>‐Naive Adults

Dennis Morrison, Thomas J. Legg, Christopher W. Billings et al. · The Journal of Infectious Diseases · 2010 · 161 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children

Arunee Sabchareon, Jean Lang, Pornthep Chanthavanich et al. · The Pediatric Infectious Disease Journal · 2004 · 145 citations

Medicine, Child Health, Pediatrics +17

Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study

Tanya Simuni, Liz Uribe, Hyunkeun Ryan Cho et al. · The Lancet Neurology · 2019 · 139 citations · Full text

Life Sciences, Neurology, Neuroscience +17